Genetic ablation of ZFAS1 profoundly compromised clonogenic potential, evidenced by 68 % reduction in tumor sphere formation capacity, concomitant with downregulation of stemness-associated surface markers (CD133, EPCAM) and activation of caspase-3-dependent apoptotic pathways. The gene discussed is ZFAS1; the disease is neoplasm.